1. Home
  2. SDHC vs OSUR Comparison

SDHC vs OSUR Comparison

Compare SDHC & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith Douglas Homes Corp.

SDHC

Smith Douglas Homes Corp.

HOLD

Current Price

$19.99

Market Cap

176.7M

Sector

N/A

ML Signal

HOLD

Logo OraSure Technologies Inc.

OSUR

OraSure Technologies Inc.

HOLD

Current Price

$2.47

Market Cap

177.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDHC
OSUR
Founded
2008
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
176.7M
177.2M
IPO Year
2024
1986

Fundamental Metrics

Financial Performance
Metric
SDHC
OSUR
Price
$19.99
$2.47
Analyst Decision
Hold
Hold
Analyst Count
5
2
Target Price
$16.70
$3.00
AVG Volume (30 Days)
80.5K
797.4K
Earning Date
11-05-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$998,173,000.00
$125,703,000.00
Revenue This Year
$0.47
N/A
Revenue Next Year
$7.65
$3.70
P/E Ratio
N/A
N/A
Revenue Growth
10.26
N/A
52 Week Low
$15.00
$2.08
52 Week High
$33.72
$4.22

Technical Indicators

Market Signals
Indicator
SDHC
OSUR
Relative Strength Index (RSI) 59.15 48.23
Support Level $20.31 $2.44
Resistance Level $21.19 $2.60
Average True Range (ATR) 1.05 0.13
MACD 0.23 0.04
Stochastic Oscillator 68.56 74.29

Price Performance

Historical Comparison
SDHC
OSUR

About SDHC Smith Douglas Homes Corp.

Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

Share on Social Networks: